Umoja Biopharma Appoints Igor I. Slukvin, M.D., Ph.D. to its Scientific Advisory Board
SEATTLE, Sept. 13, 2022 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,…
SEATTLE, Sept. 13, 2022 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,…
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Collaboration leverages Nacuity’s NPI-001 for the treatment of fatal rare disease HCCAA in Iceland FORT…
Collaboration leverages Nacuity’s NPI-001 for the treatment of fatal rare disease HCCAA in Iceland FORT…
— Expected to be accretive to 2023 earnings — DEER PARK, Ill., Sept. 13, 2022…
— Expected to be accretive to 2023 earnings — DEER PARK, Ill., Sept. 13, 2022…
HAMILTON, BERMUDA , Sept. 13, 2022 (GLOBE NEWSWIRE) — Study has reached extended enrollment target…
HAMILTON, BERMUDA , Sept. 13, 2022 (GLOBE NEWSWIRE) — Study has reached extended enrollment target…
Leaders From All Facets of Healthcare Will Collaborate to Drive Digital Innovation and Adoption BrightInsight…
Leaders From All Facets of Healthcare Will Collaborate to Drive Digital Innovation and Adoption BrightInsight…
The state-of-the-art training center is the first of its kind to further best practices with…
The state-of-the-art training center is the first of its kind to further best practices with…
Three clinical sites are now fully open; final three sites expected to open imminently ASHBURN,…
Three clinical sites are now fully open; final three sites expected to open imminently ASHBURN,…
ARID1a- mutated gastric carcinoma model (SNU-1) Tumor volumes over time FORT LEE, N.J., Sept. 13,…
ARID1a- mutated gastric carcinoma model (SNU-1) Tumor volumes over time FORT LEE, N.J., Sept. 13,…
FREMONT, CA, Sept. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (Nasdaq:…
FREMONT, CA, Sept. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (Nasdaq:…
WOBURN, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…